3
NOtl? tmpmvcxi high-performance liquid chmmatqraphic separation of decompo- skion products of prednisolone hy adding sufphite to the mobik phase Under anaerobicconditions, decompositionof corticosteroids occur~r-~, and optimal separation of important anaerobic decomposition products of prednkolone has been obtained by high-performance liquid chromatography (HPLC) using partition chromatographyx. An important decomposition product of prednisoloneis the 17-ketosteroid ( I Ifi-hydroxy-I +androstadienc-3,17-dioney_ Masod earlier reported that under anaercbic a&aline conditions, 50% of the amount of cortisone initialIy present was converted into the 17-ketosteroid (I$-androstadiene-3,i 1,174rione). Decomposition of corticosteroids into the 21-dehydro-compound has been reportedb-’ to occur under oxidztive conditions_ In our partition chromatographic method, 2l-dehydroprcdnisoione and the I7-ketostetoid (1 I/?-hydroxy-1,4-androstadiene-3,1%dione) havean identical k’ value. The separation of thesetwo compoundscould be accomplished by adding sulphite to the mcbiIe phase. In our studies on the anaerobic decompositionof prednisolone, we are now able to detect the presence of 21-dehydroprednisoione. producedby undesirable oxi- dative decomposition. MA.-i-EJuALs .4ND METHODS The chemicals used were of European Pharmacopoeia quality unless men- tioned otherwise_ 21Dehydroprednisolone was prepared by oxidation of prednisolone with copper (II) acetatein methanol, accordingto Conberc and Fanwoods. The 17-ketosteroid ofprednisolone (1 l#I-hydroxy-l&.ndrostadiene-3,17dione) was isolatedfrom the decomposition mixture of prednisolone as descried by Decker and BGjs5. . A liquid chromatograph (Waters Assoc., Milford, MA, U.S.A.), a stainless- steel column (30 cm x 3.9 mm I.D.), and a variable-wavelength detector (pye Uni- cam EC3 UV de*%tor) were used. Detection was performedat 240 nm. The column packing was porous silica pa&&s, permanently bonded to a monomo!ecular layer of organosilane@Bondapak CzB; Waters AssocJ. The com-

Improved high-performance liquid chromatographic separation of decomposition products of prednisolone by adding sulphite to the mobile phase

Embed Size (px)

Citation preview

NOtl?

tmpmvcxi high-performance liquid chmmatqraphic separation of decompo- skion products of prednisolone hy adding sufphite to the mobik phase

Under anaerobic conditions, decomposition of corticosteroids occur~r-~, and optimal separation of important anaerobic decomposition products of prednkolone has been obtained by high-performance liquid chromatography (HPLC) using partition chromatographyx.

An important decomposition product of prednisolone is the 17-ketosteroid ( I Ifi-hydroxy-I +androstadienc-3,17-dioney_ Masod earlier reported that under anaercbic a&aline conditions, 50% of the amount of cortisone initialIy present was converted into the 17-ketosteroid (I$-androstadiene-3,i 1,174rione).

Decomposition of corticosteroids into the 21-dehydro-compound has been reportedb-’ to occur under oxidztive conditions_

In our partition chromatographic method, 2l-dehydroprcdnisoione and the I7-ketostetoid (1 I/?-hydroxy-1,4-androstadiene-3,1%dione) have an identical k’ value. The separation of these two compounds could be accomplished by adding sulphite to the mcbiIe phase.

In our studies on the anaerobic decomposition of prednisolone, we are now able to detect the presence of 21-dehydroprednisoione. produced by undesirable oxi- dative decomposition.

MA.-i-EJuALs .4ND METHODS

The chemicals used were of European Pharmacopoeia quality unless men- tioned otherwise_

21Dehydroprednisolone was prepared by oxidation of prednisolone with copper (II) acetate in methanol, according to Conberc and Fanwoods.

The 17-ketosteroid ofprednisolone (1 l#I-hydroxy-l&.ndrostadiene-3,17dione) was isolated from the decomposition mixture of prednisolone as descried by Decker and BGjs5. .

A liquid chromatograph (Waters Assoc., Milford, MA, U.S.A.), a stainless- steel column (30 cm x 3.9 mm I.D.), and a variable-wavelength detector (pye Uni- cam EC3 UV de*%tor) were used. Detection was performed at 240 nm.

The column packing was porous silica pa&&s, permanently bonded to a monomo!ecular layer of organosilane @Bondapak CzB; Waters AssocJ. The com-

Fq. 1. (A) HPLC of the Ntmte of the C .amposition mixture of pnxinisolone with added 21- dehydropfcdnko!on solvent: mfaanol-VKter <l:l, w/w). to which 1% (v/w) of a O-4 M sodium phosphate soWion oEpH 7.0 was added. C&mm: ~Bondapak (30 cm x 39 mm LD.); temperature, 25°C; tlow-ratc, 1.0 m&nh; waveibgth, 240 nm; sensitivity, 0.64 a.u.ts. (B) As (A), except that sodium surpm (0.1 “/, w/w) was added to the mowe phase.

position of the mobile phase was methanol (analytical-reagent grade)-water (l:1, w/w)_ To this solvent, 1 oA (v/w) of a 0.4 M sodium phasphate solution of pH 7.0 was added. Sodium sdphitc (analytical-reagent grade) was optionally added to give a concen*~&on of 0.1% (w/w)_ The flow-rate was 1.0 ml/min and the sensitivie was 0.64 a.u.f_s_

RESULTS AND DISCUSSION

Addition of 21dehydroprcdnisolone to the filtrate of a decomposition mixture of prcdnisoione which was obtained under severe auaerobic alkaline condition9 is not detected when the solvent without sodium sulphite is used (Fig. lA)_ After the addition of sodium sulphite to the solvent, 21dehydroprednisolone (peak 2) is separated from the 17-ketosteroid (1 I@-hydroxy-1,4_androstadiene_3,174ione) (peak I) and other products (Fig. IF%)_ This separation may be due to the formation of an addition product of hydrogen sulphitc with the aldehyde group of 21dehydre prednisolone, resulting in a decrease in lipophilicity.

In this way, we are able to detect the presence of 21-dehydroprednisolone in anaerobic decomposition mixtures of prednisolone. This product, due to oxidative decomposition, should be absent under compIetely anaerobic conditions_ When the formation of the 17-ketosteroid is determined by partition chromatography with a solvent without sodium suIph;-te, 21dehydroprednisolone will interfere.

ACKNOWLEDGEMENT

We thank A. C. Beijnen for critically reading the manuscript.

AREFERENCES

1 D. Dckker, Phansz. WeekM Sci. Ed_, 1 (1979) 112_ 2 D_ E. Guttman and P. D. Meister, i. Amer. Pharm. Assw. Sci. Ed., 47 (1958) 773. : H. L. Masun, Prcw. Sz@ tWeer. &fuyo Ch., 13 (1938) 235. 4 N_ L. Wendler and R. P. Graber, Ckenz. Iti_ (.hr&n~, (1956) 549. 5 D_ Kkkker 2nd D_ J_ Buijs_ Phmz_ U’eekbi. _Sci_ EL. 2 (19%) April. 6 C. Man&r, -log); 82 (1968) 318. 7 P. Connor, i_ Pkarnz. Pkmxacd, 76 (1975) 69P_ S J_ P_ Cohere and N_ J_ Fanwocd. Us. Par_, 2,773,007_